- Home
- BW vs FENC Comparison
BW vs FENC Comparison
Compare BW & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- FENC
- Stock Information
- Founded
- BW 1867
- FENC 1996
- Country
- BW United States
- FENC United States
- Employees
- BW N/A
- FENC N/A
- Industry
- BW Building Products
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BW Industrials
- FENC Health Care
- Exchange
- BW Nasdaq
- FENC Nasdaq
- Market Cap
- BW 182.0M
- FENC 156.9M
- IPO Year
- BW N/A
- FENC 2001
- Fundamental
- Price
- BW $1.51
- FENC $5.73
- Analyst Decision
- BW Strong Buy
- FENC Strong Buy
- Analyst Count
- BW 3
- FENC 2
- Target Price
- BW $4.50
- FENC $14.00
- AVG Volume (30 Days)
- BW 1.3M
- FENC 66.9K
- Earning Date
- BW 03-13-2025
- FENC 11-07-2024
- Dividend Yield
- BW N/A
- FENC N/A
- EPS Growth
- BW N/A
- FENC N/A
- EPS
- BW N/A
- FENC N/A
- Revenue
- BW $878,224,000.00
- FENC $49,348,000.00
- Revenue This Year
- BW N/A
- FENC $170.43
- Revenue Next Year
- BW N/A
- FENC $6.70
- P/E Ratio
- BW N/A
- FENC N/A
- Revenue Growth
- BW N/A
- FENC 278.09
- 52 Week Low
- BW $0.75
- FENC $3.96
- 52 Week High
- BW $2.99
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- BW 39.38
- FENC 46.47
- Support Level
- BW $1.60
- FENC $5.47
- Resistance Level
- BW $1.67
- FENC $6.19
- Average True Range (ATR)
- BW 0.10
- FENC 0.26
- MACD
- BW 0.00
- FENC -0.08
- Stochastic Oscillator
- BW 15.38
- FENC 23.85
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.